# Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects

> **NCT04908995** · PHASE1 · COMPLETED · sponsor: **EicOsis Human Health Inc.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** EC5026 oral tablet
- **OTHER:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04908995
- **Lead sponsor:** EicOsis Human Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-30
- **Primary completion:** 2021-05-12
- **Final completion:** 2021-11-24
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908995, "Safety, Tolerability, Pharmacokinetics and Food Effects of Oral EC5026 in Healthy Subjects". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT04908995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*